Upload

Loading...

This video is private.

If the owner of this video has granted you access, please log in.

Watch Queue

TV Queue

Watch QueueTV Queue

    Loading...

Watch Queue
TV Queue
__count__/__total__
  1. 100

    Yoseline's story -- USA

  2. 101

    Complex realities of global healthcare

  3. 102

    Novartis CEO Joe Jimenez: What do you tell a team that has failed?

  4. 103

    Each Voice Counts - The Experts

  5. 104

    The voice of advanced breast cancer patients on The Balancing Act® show

  6. 105

    The Next Generation Scientist 2012

  7. 106

    Novartis CEO Joe Jimenez: The best advice I ever got

  8. 107

    Each Voice Counts - The Family

  9. 108

    Periodic fever syndromes

  10. 109

    Journey of Chronic Myeloid Leukemia: A collaborative effort between the EHA and Novartis

  11. 110

    A lifelong challenge: periodic fever syndromes

  12. 111

    Connections

  13. 112

    Each Voice Counts - The Women: Part 1

  14. 113

    Each Voice Counts - The Women: Part 2

  15. 114

    Unanswered questions about living with advanced breast cancer

  16. 115

    Count Us, Know Us, Join Us - The Path of Advanced Breast Cancer

  17. 116

    Novartis International Biotechnology Leadership Camp 2012

  18. 117

    Journey of Chronic Myeloid Leukemia (CML)

  19. 118

    A look at the past decade in GIST: Chapter 6

  20. 119

    A look at the past decade in GIST: Chapter 5

  21. 120

    A look at the past decade in GIST: Chapter 4

  22. 121

    Vision loss due to Retinal Vein Occlusion (RVO)

  23. 122

    Vision loss due to Diabetic Macular Edema (DME)

  24. 123

    Vision loss due to wet age-related macular degeneration (wet AMD)

  25. 124

    A look at the past decade in GIST: Chapter 3

  26. 125

    Building the next generation of scientists

  27. 126

    A look at the past decade in GIST: Chapter 2

  28. 127

    A look at the past decade in GIST: Chapter 1

  29. 128

    The impact of systemic juvenile idiopathic arthritis (SJIA)

  30. 129

    A difficult diagnosis: Understanding systemic juvenile idiopathic arthritis (SJIA)

  31. 130

    Advanced breast cancer 101

  32. 131

    The mTOR pathway in ER+ advanced breast cancer

  33. 132

    Life in a Circle

  34. 133

    Understanding advanced breast cancer

  35. 134

    A Gift for Living

  36. 135

    The Villages Miles Away

  37. 136

    Be Healthy: the first company-wide health and well-being initiative at Novartis

  38. 137

    Could your dog or cat be suffering from an allergy?

  39. 138

    Innovating to help eliminate malaria

  40. 139

    Malaria milestone video message

  41. 140

    Leo and Kya, friends against malaria

  42. 141

    The need for progress: what if?

  43. 142

    The myelofibrosis educational journey

  44. 143

    Understanding the progression of myelofibrosis

  45. 144

    Understanding the management of myelofibrosis

  46. 145

    The myelofibrosis disease burden

  47. 146

    The disease pathway associated with myelofibrosis

  48. 147

    New research developments in myelofibrosis

  49. 148

    Delivery of child-friendly antimalarial hits the 100 million mark

  50. 149

    Treating India's Leprosy patients

  51. 150

    Treating leprosy, caring for patients

  52. 151

    "SMS for Life" is expanding

  53. 152

    Becoming Christopher a fictional video trailer about living with Cystic Fibrosis

  54. 153

    Critical issues facing the advanced breast cancer patient community

  55. 154

    Advice to newly diagnosed advanced breast cancer patients

  56. 155

    Insight into the advanced breast cancer patient journey

  57. 156

    Pioneering an innovative social business model to fight malaria

  58. 157

    New media: drivers of democratization and development?

  59. 158

    What is it like living with myelofibrosis (MF)?

  60. 159

    What is the prognosis of myelofibrosis (MF)?

  61. 160

    How are myeloproliferative neoplasms (MPNs) diagnosed?

  62. 161

    What do we know about the development of myeloproliferative neoplasms (MPNs)?

  63. 162

    What is myelofibrosis (MF)?

  64. 163

    How is the patient journey for advanced breast cancer patients different?

  65. 164

    What is hormone receptor positive (ER+/HER2-) advanced breast cancer?

  66. 165

    What is progression free survival and why is it important?

  67. 166

    What guidance do you give patients and family coping with advanced breast cancer?

  68. 167

    What insights can you share with newly diagnosed patients?

  69. 168

    Molecular pathways:The future of research at NIBR

  70. 169

    The importance of organ donation

  71. 170

    Novartis BioCamp 2011 (German)

  72. 171

    Novartis BioCamp 2011 (French)

  73. 172

    How is research in advanced breast cancer evolving?

  74. 173

    What is hormone receptor positive (ER+/HER2-) advanced breast cancer?

  75. 174

    What can a patient expect if diagnosed with advanced breast cancer?

  76. 175

    What is progression free survival (PFS) as it relates to metastatic breast cancer therapy?

  77. 176

    What is the evolution of treatments and the progress that has been made in metastatic breast cancer?

  78. 177

    How does the advanced breast cancer treatment journey differ for patients?

  79. 178

    Novartis Be Healthy

  80. 179

    Novartis BioCamp 2011

  81. 180

    A sign from above

  82. 181

    Charlie

  83. 182

    Happy endings

  84. 183

    Herpes #1

  85. 184

    Herpes it's black and white

  86. 185

    Herpes the Ninja virus

  87. 186

    Magical elves with HSV

  88. 187

    Open happiness

  89. 188

    Play it smart

  90. 189

    Quarantine

  91. 190

    Strings

  92. 191

    Ah! Real herpes

  93. 192

    Down there

  94. 193

    Don't let herpes put you off

  95. 194

    Arogya Parivar: A social business model to improve health in rural India

  96. 195

    Living with multiple myeloma

  97. 196

    What are the symptoms of myelofibrosis (MF)?

  98. 197

    Gastrointestinal Stromal Tumors (GIST): A rare, life-threatening cancer

  99. 198

    Animals & Research: Think how far we've come

Loading...
Working...
to add this to Watch Later

Add to